Protein | Taxonomy | Measurement | Average (µ) | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
Chain A, TYROSYL-DNA PHOSPHODIESTERASE | Homo sapiens (human) | Potency | 19.9526 | 0.0040 | 23.8416 | 100.0000 | AID485290 |
Luciferase | Photinus pyralis (common eastern firefly) | Potency | 6.4347 | 0.0072 | 15.7588 | 89.3584 | AID1224835 |
interleukin 8 | Homo sapiens (human) | Potency | 66.8242 | 0.0473 | 49.4806 | 74.9780 | AID651758 |
acetylcholinesterase | Homo sapiens (human) | Potency | 73.4187 | 0.0025 | 41.7960 | 15,848.9004 | AID1347399 |
pregnane X receptor | Rattus norvegicus (Norway rat) | Potency | 45.8577 | 0.0251 | 27.9203 | 501.1870 | AID651751 |
RAR-related orphan receptor gamma | Mus musculus (house mouse) | Potency | 12.3153 | 0.0060 | 38.0041 | 19,952.5996 | AID1159521; AID1159523 |
SMAD family member 2 | Homo sapiens (human) | Potency | 59.3594 | 0.1737 | 34.3047 | 61.8120 | AID1346924 |
SMAD family member 3 | Homo sapiens (human) | Potency | 59.3594 | 0.1737 | 34.3047 | 61.8120 | AID1346924 |
GLI family zinc finger 3 | Homo sapiens (human) | Potency | 51.6717 | 0.0007 | 14.5928 | 83.7951 | AID1259368; AID1259369; AID1259392 |
AR protein | Homo sapiens (human) | Potency | 29.2962 | 0.0002 | 21.2231 | 8,912.5098 | AID588516; AID743035; AID743042; AID743054; AID743063 |
caspase 7, apoptosis-related cysteine protease | Homo sapiens (human) | Potency | 3.5568 | 0.0133 | 26.9810 | 70.7614 | AID1346978 |
thyroid stimulating hormone receptor | Homo sapiens (human) | Potency | 7.9433 | 0.0013 | 18.0743 | 39.8107 | AID926; AID938 |
estrogen receptor 2 (ER beta) | Homo sapiens (human) | Potency | 29.9765 | 0.0006 | 57.9133 | 22,387.1992 | AID1259377; AID1259378 |
nuclear receptor subfamily 1, group I, member 3 | Homo sapiens (human) | Potency | 23.5450 | 0.0010 | 22.6508 | 76.6163 | AID1224838; AID1224839; AID1224893 |
progesterone receptor | Homo sapiens (human) | Potency | 52.4648 | 0.0004 | 17.9460 | 75.1148 | AID1346795 |
glucocorticoid receptor [Homo sapiens] | Homo sapiens (human) | Potency | 12.7253 | 0.0002 | 14.3764 | 60.0339 | AID720692 |
retinoic acid nuclear receptor alpha variant 1 | Homo sapiens (human) | Potency | 4.3310 | 0.0030 | 41.6115 | 22,387.1992 | AID1159552; AID1159553; AID1159555 |
retinoid X nuclear receptor alpha | Homo sapiens (human) | Potency | 24.5412 | 0.0008 | 17.5051 | 59.3239 | AID1159527 |
estrogen-related nuclear receptor alpha | Homo sapiens (human) | Potency | 22.6158 | 0.0015 | 30.6073 | 15,848.9004 | AID1224841; AID1224842; AID1224848; AID1224849; AID1259401; AID1259403 |
farnesoid X nuclear receptor | Homo sapiens (human) | Potency | 41.9731 | 0.3758 | 27.4851 | 61.6524 | AID743217; AID743220 |
pregnane X nuclear receptor | Homo sapiens (human) | Potency | 39.2813 | 0.0054 | 28.0263 | 1,258.9301 | AID1346982; AID720659 |
estrogen nuclear receptor alpha | Homo sapiens (human) | Potency | 36.0613 | 0.0002 | 29.3054 | 16,493.5996 | AID1259244; AID1259383; AID743069; AID743075; AID743078; AID743079; AID743080; AID743091 |
peroxisome proliferator activated receptor gamma | Homo sapiens (human) | Potency | 12.3002 | 0.0010 | 19.4141 | 70.9645 | AID588537; AID743191 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | Homo sapiens (human) | Potency | 48.9662 | 0.0237 | 23.2282 | 63.5986 | AID743222 |
caspase-3 | Homo sapiens (human) | Potency | 3.5568 | 0.0133 | 26.9810 | 70.7614 | AID1346978 |
aryl hydrocarbon receptor | Homo sapiens (human) | Potency | 16.6823 | 0.0007 | 23.0674 | 1,258.9301 | AID651777; AID743085; AID743122 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | Homo sapiens (human) | Potency | 2.8253 | 0.0017 | 23.8393 | 78.1014 | AID743083 |
activating transcription factor 6 | Homo sapiens (human) | Potency | 59.2434 | 0.1434 | 27.6121 | 59.8106 | AID1159516 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | Homo sapiens (human) | Potency | 52.8008 | 19.7391 | 45.9784 | 64.9432 | AID1159509 |
v-jun sarcoma virus 17 oncogene homolog (avian) | Homo sapiens (human) | Potency | 30.8722 | 0.0578 | 21.1097 | 61.2679 | AID1159526; AID1159528 |
Histone H2A.x | Cricetulus griseus (Chinese hamster) | Potency | 89.3857 | 0.0391 | 47.5451 | 146.8240 | AID1224845; AID1224896 |
thyroid hormone receptor beta isoform a | Homo sapiens (human) | Potency | 0.0020 | 0.0100 | 39.5371 | 1,122.0200 | AID588545 |
potassium voltage-gated channel subfamily H member 2 isoform d | Homo sapiens (human) | Potency | 39.8107 | 0.0178 | 9.6374 | 44.6684 | AID588834 |
thyroid hormone receptor beta isoform 2 | Rattus norvegicus (Norway rat) | Potency | 0.9689 | 0.0003 | 23.4451 | 159.6830 | AID743065; AID743067 |
histone deacetylase 9 isoform 3 | Homo sapiens (human) | Potency | 17.2612 | 0.0376 | 17.0823 | 61.1927 | AID1259364; AID1259388 |
heat shock protein beta-1 | Homo sapiens (human) | Potency | 50.9966 | 0.0420 | 27.3789 | 61.6448 | AID743210; AID743228 |
nuclear factor erythroid 2-related factor 2 isoform 1 | Homo sapiens (human) | Potency | 18.3147 | 0.0006 | 27.2152 | 1,122.0200 | AID651741; AID720636; AID743202; AID743219 |
lethal factor (plasmid) | Bacillus anthracis str. A2012 | Potency | 31.6228 | 0.0200 | 10.7869 | 31.6228 | AID912 |
Voltage-dependent calcium channel gamma-2 subunit | Mus musculus (house mouse) | Potency | 54.4827 | 0.0015 | 57.7890 | 15,848.9004 | AID1259244 |
Cellular tumor antigen p53 | Homo sapiens (human) | Potency | 33.7278 | 0.0023 | 19.5956 | 74.0614 | AID651631 |
Glutamate receptor 2 | Rattus norvegicus (Norway rat) | Potency | 54.4827 | 0.0015 | 51.7393 | 15,848.9004 | AID1259244 |
ATPase family AAA domain-containing protein 5 | Homo sapiens (human) | Potency | 34.8612 | 0.0119 | 17.9420 | 71.5630 | AID651632; AID720516 |
Ataxin-2 | Homo sapiens (human) | Potency | 28.2529 | 0.0119 | 12.2221 | 68.7989 | AID651632 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |
Process | via Protein(s) | Taxonomy |
transcription cis-regulatory region binding | Cellular tumor antigen p53 | Homo sapiens (human) |
RNA polymerase II cis-regulatory region sequence-specific DNA binding | Cellular tumor antigen p53 | Homo sapiens (human) |
DNA-binding transcription factor activity, RNA polymerase II-specific | Cellular tumor antigen p53 | Homo sapiens (human) |
cis-regulatory region sequence-specific DNA binding | Cellular tumor antigen p53 | Homo sapiens (human) |
core promoter sequence-specific DNA binding | Cellular tumor antigen p53 | Homo sapiens (human) |
TFIID-class transcription factor complex binding | Cellular tumor antigen p53 | Homo sapiens (human) |
DNA-binding transcription repressor activity, RNA polymerase II-specific | Cellular tumor antigen p53 | Homo sapiens (human) |
DNA-binding transcription activator activity, RNA polymerase II-specific | Cellular tumor antigen p53 | Homo sapiens (human) |
protease binding | Cellular tumor antigen p53 | Homo sapiens (human) |
p53 binding | Cellular tumor antigen p53 | Homo sapiens (human) |
DNA binding | Cellular tumor antigen p53 | Homo sapiens (human) |
chromatin binding | Cellular tumor antigen p53 | Homo sapiens (human) |
DNA-binding transcription factor activity | Cellular tumor antigen p53 | Homo sapiens (human) |
mRNA 3'-UTR binding | Cellular tumor antigen p53 | Homo sapiens (human) |
copper ion binding | Cellular tumor antigen p53 | Homo sapiens (human) |
protein binding | Cellular tumor antigen p53 | Homo sapiens (human) |
zinc ion binding | Cellular tumor antigen p53 | Homo sapiens (human) |
enzyme binding | Cellular tumor antigen p53 | Homo sapiens (human) |
receptor tyrosine kinase binding | Cellular tumor antigen p53 | Homo sapiens (human) |
ubiquitin protein ligase binding | Cellular tumor antigen p53 | Homo sapiens (human) |
histone deacetylase regulator activity | Cellular tumor antigen p53 | Homo sapiens (human) |
ATP-dependent DNA/DNA annealing activity | Cellular tumor antigen p53 | Homo sapiens (human) |
identical protein binding | Cellular tumor antigen p53 | Homo sapiens (human) |
histone deacetylase binding | Cellular tumor antigen p53 | Homo sapiens (human) |
protein heterodimerization activity | Cellular tumor antigen p53 | Homo sapiens (human) |
protein-folding chaperone binding | Cellular tumor antigen p53 | Homo sapiens (human) |
protein phosphatase 2A binding | Cellular tumor antigen p53 | Homo sapiens (human) |
RNA polymerase II-specific DNA-binding transcription factor binding | Cellular tumor antigen p53 | Homo sapiens (human) |
14-3-3 protein binding | Cellular tumor antigen p53 | Homo sapiens (human) |
MDM2/MDM4 family protein binding | Cellular tumor antigen p53 | Homo sapiens (human) |
disordered domain specific binding | Cellular tumor antigen p53 | Homo sapiens (human) |
general transcription initiation factor binding | Cellular tumor antigen p53 | Homo sapiens (human) |
molecular function activator activity | Cellular tumor antigen p53 | Homo sapiens (human) |
promoter-specific chromatin binding | Cellular tumor antigen p53 | Homo sapiens (human) |
monooxygenase activity | Cytochrome P450 1A1 | Homo sapiens (human) |
iron ion binding | Cytochrome P450 1A1 | Homo sapiens (human) |
protein binding | Cytochrome P450 1A1 | Homo sapiens (human) |
arachidonic acid monooxygenase activity | Cytochrome P450 1A1 | Homo sapiens (human) |
oxidoreductase activity | Cytochrome P450 1A1 | Homo sapiens (human) |
oxidoreductase activity, acting on diphenols and related substances as donors | Cytochrome P450 1A1 | Homo sapiens (human) |
flavonoid 3'-monooxygenase activity | Cytochrome P450 1A1 | Homo sapiens (human) |
oxygen binding | Cytochrome P450 1A1 | Homo sapiens (human) |
enzyme binding | Cytochrome P450 1A1 | Homo sapiens (human) |
heme binding | Cytochrome P450 1A1 | Homo sapiens (human) |
Hsp70 protein binding | Cytochrome P450 1A1 | Homo sapiens (human) |
demethylase activity | Cytochrome P450 1A1 | Homo sapiens (human) |
Hsp90 protein binding | Cytochrome P450 1A1 | Homo sapiens (human) |
aromatase activity | Cytochrome P450 1A1 | Homo sapiens (human) |
vitamin D 24-hydroxylase activity | Cytochrome P450 1A1 | Homo sapiens (human) |
estrogen 16-alpha-hydroxylase activity | Cytochrome P450 1A1 | Homo sapiens (human) |
estrogen 2-hydroxylase activity | Cytochrome P450 1A1 | Homo sapiens (human) |
long-chain fatty acid omega-hydroxylase activity | Cytochrome P450 1A1 | Homo sapiens (human) |
hydroperoxy icosatetraenoate dehydratase activity | Cytochrome P450 1A1 | Homo sapiens (human) |
long-chain fatty acid omega-1 hydroxylase activity | Cytochrome P450 1A1 | Homo sapiens (human) |
monooxygenase activity | Cytochrome P450 1B1 | Homo sapiens (human) |
iron ion binding | Cytochrome P450 1B1 | Homo sapiens (human) |
protein binding | Cytochrome P450 1B1 | Homo sapiens (human) |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen | Cytochrome P450 1B1 | Homo sapiens (human) |
heme binding | Cytochrome P450 1B1 | Homo sapiens (human) |
aromatase activity | Cytochrome P450 1B1 | Homo sapiens (human) |
estrogen 16-alpha-hydroxylase activity | Cytochrome P450 1B1 | Homo sapiens (human) |
hydroperoxy icosatetraenoate dehydratase activity | Cytochrome P450 1B1 | Homo sapiens (human) |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen | Cytochrome P450 1B1 | Homo sapiens (human) |
protein binding | ATPase family AAA domain-containing protein 5 | Homo sapiens (human) |
ATP binding | ATPase family AAA domain-containing protein 5 | Homo sapiens (human) |
ATP hydrolysis activity | ATPase family AAA domain-containing protein 5 | Homo sapiens (human) |
DNA clamp unloader activity | ATPase family AAA domain-containing protein 5 | Homo sapiens (human) |
DNA binding | ATPase family AAA domain-containing protein 5 | Homo sapiens (human) |
RNA binding | Ataxin-2 | Homo sapiens (human) |
epidermal growth factor receptor binding | Ataxin-2 | Homo sapiens (human) |
protein binding | Ataxin-2 | Homo sapiens (human) |
mRNA binding | Ataxin-2 | Homo sapiens (human) |
[Information is prepared from geneontology information from the June-17-2024 release] |